Keyphrases
MicroRNA
83%
MiRNA Target
29%
MicroRNA Function
29%
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
22%
MiR-181a
22%
Cancer Cells
20%
Mouse Model
20%
MHC Class I
19%
Tumor
18%
T Cells
18%
Chimeric Antigen Receptor T Cells (CAR-T)
18%
CRISPR Interference (CRISPRi)
18%
Cell Function
16%
Cellular Immunotherapy
14%
MiR-15a/16
14%
Targeted Drugs
14%
Kinetic Analysis
14%
MicroRNA-181a
14%
Evade
14%
Mammalian Cells
14%
Pathophysiology
14%
Cell Delay
14%
TP73 Gene
14%
Juvenile Myelomonocytic Leukemia
14%
Tumor-initiating Cells
14%
DNA Damage
14%
Target Specificity
14%
Induced Senescence
14%
Stem Cell Models
14%
Transgene Expression
14%
Human Tumors
14%
BRAF V600E
14%
Stem Cells
14%
PTPN11
14%
Tumor Progression
14%
Small Ubiquitin-like Modifier
14%
Quiescent Stem Cells
14%
Tissue Differentiation
14%
Tumor Microenvironment
14%
Dysregulation
14%
Immune Surveillance
14%
Cardiac Dysfunction
14%
P53 mutant
14%
MiR-146a
14%
Tissue Lineages
14%
Tumor Immunity
14%
Langerhans Cell Histiocytosis
14%
Transcriptional Repressor
14%
Physical Interaction
14%
Endosomal Recycling Compartment
14%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
CRISPR
29%
Drive
29%
Cancer Cell
17%
P73
17%
Cell Function
16%
Genomics
16%
P53
16%
Hematopoietic Cell
16%
Immunity
15%
Myeloid
14%
Kinetics
14%
Cancer Stem Cell
14%
Nucleic Acid
14%
Mir-126
14%
Stem Cell
14%
Drug Targeting
14%
Langerhans Cell
14%
PTPN11
14%
Transgene
14%
Ubiquitin
14%
Mammalian Cell
14%
Immunosurveillance
14%
Mesenchymal-Epithelial Transition
14%
Induced Pluripotent Stem Cell
14%
DNA Damage Response
14%
Infectious Agent
14%
Interleukin 4
14%
Functional Genomics
12%
Upregulation
8%
Sumoylation
8%
Gene Function
7%
T Cell
7%
Cancer Mortality
7%
Plasmacytoid Dendritic Cell
7%
Cell Survival
7%
Drug Resistance
7%
Tumor Volume
7%
Signal Transduction
7%
Revertant
7%
Ectopic Expression
7%
Macrophage
7%
Mononuclear Phagocyte
6%
Fibroblast
6%
Mass Cytometry
5%
Immunology and Microbiology
Immunotherapy
29%
Macrophage
22%
Mouse Model
17%
T Cell
17%
MHC Class I
16%
B-1 Cell
14%
Toll-Like Receptor
14%
Infectious Agent
14%
Cross-Presentation
14%
Sumoylation
14%
Stem Cell
14%
Plasmacytoid Dendritic Cell
14%
Clustered Regularly Interspaced Short Palindromic Repeat
14%
Chimeric Antigen Receptor T-Cell
14%
Immunosurveillance
14%
P53
14%
Cell Line
14%
Drug Sensitivity
14%
New Zealand Black Mouse
14%
Interleukin 4
14%
Chimeric Antigen Receptor
12%
Tumor Cell
12%
Immunity
12%
Cancer Cell
11%
Cyclin D1
9%
Cell Cycle Regulation
9%
Phagosome
8%
Upregulation
7%
Cardiac Muscle Cell
7%
Cell Cycle
6%
Mass Cytometry
5%
Tumor-Associated Macrophage
5%
Cytotoxic T-Cell
5%
Cell Killing
5%